{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA065129"
        ],
        "brand_name": [
          "CEFIXIME"
        ],
        "generic_name": [
          "CEFIXIME"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-405",
          "68180-407",
          "68180-416",
          "68180-423"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "CEFIXIME"
        ],
        "rxcui": [
          "309058",
          "409823",
          "419849"
        ],
        "spl_id": [
          "735f86f4-369c-4f5a-adbe-7dacea2e27b4"
        ],
        "spl_set_id": [
          "6d68dbd9-7d75-4ff1-91db-79ff8ae879ec"
        ],
        "package_ndc": [
          "68180-405-01",
          "68180-407-03",
          "68180-407-04",
          "68180-416-08",
          "68180-416-11",
          "68180-423-11",
          "68180-423-08"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368180423089",
          "0368180407034",
          "0368180416081",
          "0368180416111"
        ],
        "unii": [
          "97I1C92E55"
        ]
      },
      "product_type": "Drugs",
      "event_id": "95193",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "Harborplace Tower",
      "address_2": "111 S Calvert St Fl 21st",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA nationwide.",
      "recall_number": "D-0648-2024",
      "product_description": "Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01",
      "product_quantity": "4554 bottles",
      "reason_for_recall": "Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.",
      "recall_initiation_date": "20240821",
      "center_classification_date": "20240826",
      "termination_date": "20250429",
      "report_date": "20240904",
      "code_info": "Lot #: F201517, Exp 11/30/2024",
      "more_code_info": ""
    }
  ]
}